RELATED CONTENT
NEWS
- $935 million Plexxikon buy to bolster Daiichi Sankyo's oncology presence
- GSK focuses on emerging markets as European austerity bites
- Novartis eyes new product push in India as it girds for Glivec case
- Lilly and US embassy lobbied against Finnish reference pricing, says WikiLeaks
FEATURES
Other Informa Features


